Vaccine Responses in Cancer
Clinical trial NCT06605625 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06605625
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-11-04
- Primary completion
- 2027-10-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.